InvestSMART

Enlitic Inc (ASX:ENL)

ALERT: Price-sensitive ASX Announcement for ENL
Current share price for ENL : $0.008 -0.001 (-11.11%)+
Announcement
Release
29 Apr 2026 8:25AM
Price at Release
$0.009
Full Release
download
Summary
Enlitic, Inc. has reported a strong start to the fiscal year 2026 with significant contract wins resulting in a total contract value of A$5.1 million. This growth is attributed to new client agreements and partnerships with major healthcare institutions such as Penn Medicine and St. Jude Children's Research Hospital. The company has focused on enhancing its presence in the US healthcare market by leveraging its AI-powered data management platform, Ensight. Enlitic's financial performance for Q1 FY26 shows a net operating cash outflow reduction to US$2.9 million and a strong cash position with US$3.0 million at the period end. The company also implemented cost reduction measures expected to yield US$2.5 million in annual savings, and completed a capital raise to further support financial flexibility.
Key Points
  • Record contract wins of A$5.1 million in Q1 FY26.
  • Major agreements with Penn Medicine, St. Jude Children's Research Hospital, and Parkland Health.
  • 17 new client agreements focused on migration and Ensight SaaS offerings.
  • OEM partnerships include 8 global OEM engagements.
  • Net operating cash outflow reduced to US$2.9 million.
  • Convertible notes capital raise completed for A$5.4 million.
  • Trade receivables of ~US$2.5 million provide cash visibility.
  • Cost reduction measures to deliver ~US$2.5 million annual savings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.